Related Experiment Video
Updated: Jun 11, 2026
09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Vascular pathology in Alzheimer's disease
1Amakusa Hospital, Kumamoto, Japan. peter@ed.sojo-u.ac.jp
Summary
Alzheimer's disease involves brain atrophy, senile plaques, and neurofibrillary tangles. Degenerative changes in brain capillaries and blood-brain barrier alterations are key factors in Alzheimer's pathology.
Area of Science:
- Neuropathology
- Neuroscience
- Vascular Biology
Background:
- Alzheimer's disease (AD) is characterized by senile plaques and neurofibrillary tangles.
- Brain atrophy and neuronal degeneration are prominent features observed in AD.
- The role of cerebrovascular changes in AD pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the morphological relationship between amyloid fibrils, senile plaques, and cerebral microvasculature in Alzheimer's disease.
- To explore the potential contribution of vascular degeneration and blood-brain barrier alterations to neuronal atrophy in AD.
- To emphasize the significance of microvascular morphology in understanding AD mechanisms.
Main Methods:
- Histopathological examination of brain tissue from Alzheimer's disease patients.
- Light microscopy to assess neuronal atrophy.
- Electron microscopy of serial sections to examine microvascular structures and their association with amyloid deposits.
Main Results:
- Senile plaques and neurofibrillary tangles were abundant in AD brains.
- Degenerative changes were observed in small blood vessels, including capillaries, associated with amyloid fibrils.
- Degeneration of astroglial vascular feet and surrounding nerve cells was evident, suggesting a link to amyloid angiopathy and blood-brain barrier dysfunction.
Conclusions:
- Brain atrophy in Alzheimer's disease is likely caused by amyloid angiopathy and degeneration of capillaries and their associated structures.
- Alterations in the blood-brain barrier represent a major causal mechanism in Alzheimer's disease.
- Morphological changes in cerebral microvessels provide critical insights into the underlying mechanisms of Alzheimer's disease.
More Related Videos
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...